ByTrending Posts
AI Meets Neuroscience: BullFrog AI and LIBD Unlock…
Gaithersburg, Md – Jan 17 2024 BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a technology-enabled drug development company…
Nvidia Expands AI Drug Discovery with Amgen and…
JPM Conference, January 8, 2024 Nvidia is advancing its footprint in AI-powered drug discovery through new collaborations with…
Insilico Medicine Achieves Milestone with Positive Phase I…
CAMBRIDGE, Massachusetts, January 7, 2024 Insilico Medicine, a clinical-stage leader in generative AI-driven drug discovery and development, has…
Bristol Myers Squibb Taps AI-Driven Discovery with Terray…
Los Angeles – Dec 14, 2023 Terray Therapeutics, a leader in AI-driven small molecule discovery, has entered into…
PostEra and Amgen Forge AI Drug Discovery Partnership…
Boston – Nov 16, 2023 Advancing Small Molecule Therapeutics with AI PostEra has entered into a multi-target research…
NVIDIA Backs Terray Therapeutics to Advance Generative AI…
Los Angeles – Nov 9, 2023 Terray Therapeutics, a biotechnology company pioneering AI-driven small molecule discovery, has secured…
Merck (HQ Germany) Strengthens AI-Driven Drug Discovery with…
Darmstadt, Germany – Sept 20, 2023 Advancing AI-Powered Drug Development in Oncology, Neurology, and Immunology Merck, a global…
BenevolentAI Announces Strategic Collaboration with Merck, Darmstadt, Germany
London, UK – Sept 20, 2023 Partnership Utilizes AI-Driven Drug Discovery to Advance Oncology, Neurology, and Immunology Treatments…
XtalPi and Eli Lilly Partner in $250M AI-Driven…
Cambridge, MA – June 1 2023 XtalPi Inc., a pioneering AI-powered pharmaceutical technology company, has announced a strategic…
Trending Posts
Latest Stories
Will Novartis’ $280M Gene Therapy Plant Transform Denton into a Biopharma Hub?
Denton, TX The Denton City Council has unanimously approved an economic development agreement with Novartis…
Will Novo Nordisk Pull Ahead of Eli Lilly with FDA Approval of Oral Wegovy?
The U.S. Food and Drug Administration (FDA) has approved the first daily oral version of…
Is Tanya Alcorn Poised to Transform Pfizer’s Global Hospital and Biosimilars Strategy?
Pfizer has appointed Tanya Alcorn as President, Global Hospital and Biosimilars, expanding her leadership responsibilities…
Is Pfizer Facing New Safety Scrutiny After Reporting a Patient Death in Its Hympavzi Hemophilia Trial?
Pfizer has disclosed that a patient enrolled in a clinical trial evaluating its investigational hemophilia…
Gallery
